Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP): Prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide

Brain Research

Volumn 809, Issue 1, 1998, Pages 58-67

  Cosi, Cristina ^a   Marien, Marc ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); Adenosine triphosphate (ATP); Benzamide; C57BL 6N mouse; Nicotinamide adenine dinucleotide (NAD+); Poly(ADP ribose) polymerase (PARP)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3 O METHYLDOPAMINE; ADENOSINE TRIPHOSPHATE; BENZAMIDE; DOPAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ENZYME INHIBITION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICROWAVE IRRADIATION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; 1-METHYL-4-PHENYLPYRIDINIUM; ADENOSINE DIPHOSPHATE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; BENZAMIDES; BRAIN CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; FRONTAL LOBE; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; NAD; NEUROPROTECTIVE AGENTS; POLY(ADP-RIBOSE) POLYMERASES; PROTEINS; PYRIDINIUM COMPOUNDS;

EID: 0032569674     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00829-4     Document Type: Article

References (54)

1. +): regional dopamine neuron uptake, toxicity, and novel rotational behaviour following receptor proliferation. Eur. J. Pharmacol. 131:1986;199-209.
2. Althaus F.R., Richter C. ADP-ribosylation of proteins: enzymology and biochemical significance. Mol. Biol. Biochem. Biophys. 37:1987;1-125.
3. Banasik M., Komura H., Shimoyama M., Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribose) transferase. J. Biol. Chem. 267:1992;1569-1575.
4. Castagnoli K., Palmer S., Anderson A., Bueters T., Castagnoli N. Jr. The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Chem. Res. Toxicol. 10:1997;364-368.
5. Carson D.A., Seto S., Wasson D.B., Carrera C.J. DNA strand breaks, NAD metabolism, and programmed cell death. Exp. Cell Res. 164:1986;273-281.
6. Chan P., DeLanney L.E., Irwin I., Langston J.W., Di Monte D.A. Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J. Neurochem. 57:1991;348-351.
7. Chan P., Langston J.W., Irwin I., DeLanney L.E., Di Monte D.A. 2-Deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain. J. Neurochem. 61:1993;610-616.
8. Chan P., Di Monte D.A., Luo J.J., DeLanney L.E., Irwin I., Langston J.W. Rapid ATP loss caused by methamphetamine in the mouse striatum: relationship between energy impairment and dopaminergic toxicity. J. Neurochem. 62:1994;2484-2487.
9. + on endogenous dopamine release from the rat corpus striatum superfused in vitro. Brain Res. 368:1986;134-140.
10. +. Free Radical Biology and Medicine. 13:1992;581-583.
11. Chiueh C.C., Miyake H., Peng M.-T. Role of dopamine auto-oxidation, hydroxyl radical generation, and calcium overload in underlying mechanisms involved in MPTP-induced parkinsonism. Adv. Neurol. 60:1993;251-258.
12. J.E. Cleaver, W.J. Bodell, C. Borek, W.F. Morgan, J.L. Schwartz, Poly(ADP-ribose): spectator or participant in excision repair of DNA damage, in: M. Miwa, O. Hayaishi, S. Shall, M. Smulson, T. Sugimura (Eds.), ADP-ribosylation, DNA Repair and Cancer, Proc. Int. Symp. Princess Takamatsu Cancer Res. Fund, 13th, Tokyo, 1982, Jpn. Soc. Press, Tokyo, 1983, pp. 195-207.
13. Cosi C., Chopin P., Marien M. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57Bl/6N mouse. Brain Res. 735:1996;343-348.
14. Cosi C., Colpaert F., Koek W., Degryse A., Marien M. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice. Brain Res. 729:1996;264-269.
15. Cosi C., Suzuki H., Milani D., Facci L., Menegazzi M., Vantini G., Kanai Y., Skaper S.D. Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells. J. Neurosci. Res. 39:1994;38-46.
16. + and ATP are prevented in vivo by the poly(ADP-ribose) polymerase (PARP) inhibitor, benzamide (BNZ). Soc. Neurosci. Abstr. 23:1997;274.
17. Fornai F., Alessandri M.G., Fascetti F., Vaglini F., Corsini G.U. Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice. J. Neurochem. 65:1995;704-709.
18. P. Friedman, GB-STAT: Computer Aided Statistics and Graphics, Version 3.0, Dynamic Microsystems, Silver Spring, 1991.
19. Gaal J.C., Smith K.R., Pearson C.K. Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosylation in cellular metabolism. Trends Biochem. Sci. 12:1987;128-129.
20. Gerlach M., Riederer P., Przuntek H., Youdim M.B.H. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 208:1991;273-286.
21. Giovanni A., Sonsalla P.K., Heikkila R.E. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Part 2. Central administration of 1-methyl-4-phenylpyridinium. J. Pharmacol. Exp. Ther. 270:1994;1008-1014.
22. + concentrations and neurotoxicity. Life Sci. 40:1987;731-740.
23. Johnson G.S. Benzamide and its derivatives inhibit nicotinamide methylation as well as ADP-ribosylation. Biochem. Int. 2:1981;611-617.
24. G. Jonsson, E. Sundström, E. Nwanze, H. Hallman, J. Luthman, Mode of action of MPTP on catecholaminergic neurons in the mouse, in: S.P. Markey, N. Castagnoli Jr., A.J. Trevor, I.J. Kopin (Eds.), MPTP - A Neurotoxin Producing a Parkinsonian Syndrome, Academic Press, 1986, pp. 253-272.
25. Jones D.P. Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography. J. Chromatogr. 225:1981;446-449.
26. LeDoux S.P., Hall C.R., Forbes P.M., Patton N.J., Wilson G.L. Mechanisms of nicotinamide and thymidine protection from alloxan and streptozotocin toxicity. Diabetes. 37:1988;1015-1019.
27. Lindahl T., Satoh M.S., Poirier G.G., Klungland A. Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends Biochem. Sci. 20:1995;405-411.
28. +: the effects of aging. Life Sci. 40:1987;749-754.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Marien M.R., Briley M., Colpaert F. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur. J. Pharmacol. 236:1993;487-489.
31. Markey S.P., Johannessen J.N., Chiueh C.C., Burns R.S., Herkenham M.A. Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature. 311:1984;464-466.
32. Markstein R., Lahaye D. Neurochemical investigations in vitro with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in preparations of rat brain. Eur. J. Pharmacol. 106:1985;301-311.
33. Milam M.K., Cleaver E.J. Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes. Science. 223:1984;589-591.
34. Nicotera P., Leist M. Energy supply and the shape of death in neurons and lymphoid cells. Cell Death and Differentiation. 4:1997;435-442.
35. NRC (National Research Council), Guide for the Care and Use of Laboratory Animals, National Academy Press, Washington, DC, 1996.
36. Obata T., Yamanaka Y., Chiueh C.C. In vivo release of dopamine by perfusion of 1-methyl-4-phenylpyridinium ion in the striatum with a microdialysis technique. Jpn. J. Pharmacol. 60:1992;311-313.
37. +) on dopamine and serotonin metabolism in rat striatum as assayed in vivo by a micro-dialysis technique. J. Neural Transm. 70:1987;241-250.
38. Pileblad E., Carlsson A. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Pharmacol. Toxicol. 62:1988;213-222.
39. Pileblad E., Fornstedt D., Clark A. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum. J. Pharm. Pharmacol. 37:1985;707-712.
40. Pileblad E., Nissbrandt H., Carlsson A. Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain. J. Neural Transm. 60:1984;199-203.
41. S.M. Pitts, S.P. Markey, D.L. Murphy, A. Weisz, Recommended practices for the safe handling of MPTP, in: S.P. Markey, N. Castagnoli Jr., A.J. Trevor, I.J. Kopin (Eds.), MPTP - A Neurotoxin Producing a Parkinsonian Syndrome, Academic Press, New York, 1986, pp. 703-716.
42. Redegeld A.F., Chatterjee S., Berger A.N., Sitkovsky V.M. Poly(ADP-ribose) polymerase partially contributes to target cell death triggered by cytolytic T lymphocytes. J. Immunol. 149:1992;3509-3516.
43. +. Eur. J. Pharmacol. 126:1986;345-346.
44. Rollema H., de Vries J.B., Damsma G., Westerink B.H.C., Kranenbourg G.L., Kuhr W.G., Horn A.S. The use of in vivo brain dialysis of dopamine, acetylcholine, amino acids and lactic acid in studies on the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicology. 49:1988;503-511.
45. Schraufstatter I.U., Hyslop P.A., Hinshaw D.B., Spragg R.G., Sklar L.A., Cochrane C.G. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;4908-4912.
46. Sershen H., Mason M.F., Reith M.E.A., Hashim A., Lajtha A. Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice. Neuropharmacology. 25:1986;927-930.
47. Sheng P., Cerruti C., Cadet J.L. Methamphetamine (METH) causes reactive gliosis in vitro: attenuation by the ADP-ribosylation (ADPR) inhibitor, benzamide. Pharmacol. Lett. 55:1994;PL51-PL54.
48. Smith T.S., Bennett J.P. Jr. Mitochondrial toxins in models of neurodegenerative diseases: I. In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions. Brain Res. 765:1997;183-188.
49. Tipton K.F., Singer T.P. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1993;1191-1206.
50. Vyas I., Heikkila R.E., Nicklas W.J. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NADH-linked substrate oxidation by its metabolite 1-methyl-4-phenylpyridinium. J. Neurochem. 46:1986;1501-1507.
51. Westerink B.H.C., Tuntler J., Damsma G., Rollema H., de Vries J.B. The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;502-507.
52. Wood P.L., Altar C.A. Dopamine release in vivo from nigrostriatal, mesolimbic and mesocortical neurons: utility of 3-methoxytyramine measurements. Pharmacological Rev. 40:1988;163-187.
53. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263:1994;687-689.
54. + neurotoxicity and delays its elimination from the striatum. Brain Res. 501:1989;11-22.